Series A · AI & Machine Learning · Cambridge, United Kingdom · Founded 2018 · 40–50 employees
Qureight is a clinical data analytics company that develops AI-powered imaging platforms for drug development in lung and heart diseases. The company curates and analyzes complex clinical imaging data, helping pharmaceutical companies accelerate clinical trials by providing automated image analysis and digital biomarkers. Founded in 2018 by Dr. Muhunthan Thillai and Dr. Alessandro Ruggiero, both practicing clinicians, the company has secured significant partnerships with major pharma companies including Takeda, Galapagos, and Roche. In 2024, they raised €8 million in Series A funding to expand their AI-driven product portfolio into new diseases including lung cancer.